Search

everythinglearnresearchcommunity

for

Search:↓

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Male hormones worsen kidney transplant damage, but blocking them helps.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Male rats have androgen receptors in their liver, which are different from proteins that bind estrogen.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Hair restoration surgery can lead to swelling, infections, scarring, numbness, hiccups, and poor hair growth.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

More research is needed to determine if iron deficiency causes hair loss.

Compounds from Angelica koreana roots, especially osthenol, could be effective for treating conditions like prostate disease and hair loss.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Platelet-rich plasma (PRP) treatment has been found effective in promoting hair growth for alopecia patients, with minimal side effects like temporary pain and redness.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

First Korean case of Cronkhite-Canada syndrome with colon cancer and serrated adenoma.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Male hormones indirectly affect skin cell development by increasing growth factor levels from skin fibroblasts.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Dermabrasion improves skin appearance by removing the top layer to promote healing.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.